With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

The new recipients of 23andMe’s data would not necessarily have to offer consumers the ability to opt out once they take possession of it. And it remains unclear which (or how many) hands the data ...

Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...

German airline Lufthansa's air freight business said on Friday it is experiencing an increase in demand for pharmaceutical ...

Money may soon start trickling in from a nearly decade-long legal battle with pharmaceutical companies accused of conspiring ...

AG Kwame Raoul files for approval of a $39.1 million settlement with Apotex Inc. over drug price inflation claims.

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

"The government should step in to facilitate lower prices, as has occurred in the rest of the world," writes one reader.

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...